You are here: Industry Insights > 2-DG

News List

BDR Pharmaceuticals announces license agreement with DRDO to manufacture 2-DG drug in India expresspharma
July 27, 2021
BDR Pharma has signed a license agreement with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) of the Defence Research and Development Organisation (DRDO) for the ...
Mankind Pharma gets DRDO nod to make and market 2-DG expresspharma
July 09, 2021
The company will manufacture the product at its facilities in Visakhapatnam and Himachal Pradesh.
CSIR-IICT, Anthem Biosciences partner to produce anti-COVID drug 2-DG expresspharma
June 17, 2021
The CSIR-Indian Institute of Chemical Technology (IICT) and Bengaluru-based Anthem Biosciences have entered into an agreement for technology transfer and manufacture of anti-COVID drug 2-DG.
DRDO launches anti-COVID drug 2-DG expresspharma
May 18, 2021
The first batch of DRDO-developed anti-COVID drug 2-DG (2-deoxy-D-glucose) has been launched to treat patients suffering from the deadly COVID-19. The medicine comes in powder form and can be taken with water.
Moleculin Selects IQVIA Biotech to Advance COVID Treatment contractpharma
April 08, 2021
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.